New Alzheimer's blood tests detect biomarkers like pTau217 but don't diagnose alone. They're for symptomatic patients, not routine screening. Costs aren't Medicare-funded, yet they could speed diagnosis and aid emerging treatments. Consult your GP first.
New Alzheimers Blood Tests Approved, But Experts Urge Caution
✨ Enjoying this article? ✨
📱 Get more with the NewsNuggs iOS App →